Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 4, 1997

View Archived Issues

Betulinic acid derivatives reported to have anti-HIV activity

Pfizer claims glycogen phosphorylase inhibitors

Piperidine derivatives reported by Schering-Plough

AHP claims smooth muscle cell proliferation inhibitors

Merck & Co. continues to develop farnesyl protein transferase inhibitors

Aminoisoindole derivatives discovered for neuropsychological disorders

A new class of GABA receptor ligands claimed by Neurogen

Novel diabetes treatments reported by Shaman

Hoechst develops antipsychotic agents

Takeda's new cephems

1996 in review: Adcock Ingram

Antineoplastic antibiotics isolated by Japanese investigators

Hepatoprotective activity of Chinese medicine tested in animal models

Progenics awarded grants to develop HIV therapeutics

Demeter receives funding for anticancer program

Pharma Patch restructures

Patent coverage sought for novel approach to reducing side effects of vitamin A

Marnac licenses broad-spectrum antifibrotic drug

Pall Corporation finalizes acquisition

GelMed receives patent coverage for new use of polymers

Golden and Syncor sign letter of intent

Positive results reported from TOBI pivotal trials

Cytogen/Elan oral drug delivery collaboration advances

GeneMedicine IND approved

U.S. patent for Tularik drug discovery assays

Tularik receives patent coverage for protein involved in immune response

ICOS/Glaxo Wellcome collaboration modified

U.S. launch for prostate cancer imaging agent

Gen-Probe diagnostic approved by FDA

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...